1 Tada Y,Shimada H,Hiroshima K,et al.A potential therapeutic strategy for malignant mesothelioma with gene medicine[J].Biomed Res Int,2013,2013(2013):572609-572616.
2 Shersher DD,Liptay MJ.Multimodality treatment of pleural mesothelioma[J].Surg Oncol Clin N Am,2013,22(2):345-355.
3 王芳.恶性间皮瘤治疗进展[J].实用肿瘤学杂志,2011,25(4):384-388.
4 刘伟锋,王海林,丁汉军.胃肠道间质瘤的误诊分析及鉴别诊断[J].实用肿瘤学杂志,2005,19(5):357-359.
5 Van Brocklyn JR,Williams JB.The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase:oxidative stress and the seesaw of cell survival and death[J].Comp Biochem Physiol B Biochem Mol Biol,2012,163(1):26-36.
6 Gatt S,Dagan A.Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids[J].Chem Phys Lipids,2012,165(4):462-474.
7 Kartal Yand1m M,Apohan E,Baran Y.Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer[J].Cancer Chemother Pharmacol,2013,71(1):13-20.
8 Dimanche-Boitrel MT,Rebillard A,Gulbins E.Ceramide in chemotherapy of tumors[J].Recent Pat Anticancer Drug Discov,2011,6(3):284-293.
9 Zhang TH,Liu JF,Zhang Y,et al.Ceramide induces apoptosis in human lung adenocarcinoma A549 cells through mitogen-activated protein kinases[J].Acta Pharmacol Sin,2007,28(3):439-445.
10 Woodcock J.Sphingosine and ceramide signalling in apoptosis[J].IUBMB Life,2006,58(8):462-466.
11 Gómez-Muoz A.Ceramide 1-phosphate/ceramide,a switch between life and death[J].Biochim Biophys Acta,2006,1758(12):2049-2056. |